163 results on '"Nanami, Tatsuki"'
Search Results
2. Prognostic significance of preoperative low serum creatine kinase levels in gastric cancer
3. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma
4. Preoperative low serum creatine kinase is associated with poor overall survival in the male patients with esophageal squamous cell carcinoma
5. Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers
6. Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer
7. Combination of high anti‐SKI and low anti‐TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma.
8. Serum p53 antibody: useful for detecting gastric cancer but not for predicting prognosis after surgery
9. Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1
10. Urinary N1, N12-Diacetylspermine Level in the Patients with Various Cancer; A Pilot Study in Seven Types of Cancer
11. The effectiveness of serum midkine in detecting esophageal squamous cell carcinoma
12. Is Preoperative Low Serum Calcium Level a Poor Prognostic Factor of Gastric Cancer?
13. Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinoma
14. Five-year postsurgical monitoring of serum p53 antibody for locally advanced esophageal squamous cell carcinoma
15. The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
16. Is High Score of Preoperative Lactate Dehydrogenase to Albumin Ratio Predicting Poor Survivals in Esophageal Carcinoma Patients?
17. Prospective pilot study of adoptive immunotherapy with autologous αβT cells for five cases of advanced and/or recurrent esophageal squamous cell carcinoma
18. Relationship between ABO blood group and clinicopathological factors and their effect on the survival of Japanese patients with esophageal squamous cell carcinoma
19. Negative conversion of high serum p53 antibody titers in a patient with gastric cancer at 31 months after surgery
20. Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma
21. Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer
22. Clinical significance of serum autoantibodies against Ras-like GTPases, RalA, in patients with esophageal squamous cell carcinoma
23. NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
24. Radical Esophagectomy Combined with Resection of the Invaded Descending Aorta for T4 Barrett's Esophageal Carcinoma: A Case Report
25. Comparison between a new assay system, Elecsys® Anti‑p53, and conventional MESACUP™ for the detection of serum anti‑p53 antibodies: A multi‑institutional study
26. Postrecurrence Prognostic Impact of Squamous Cell Carcinoma Antigen and Serum p53 Antibody at the Time of Recurrence on the Patients with Esophageal Squamous Cell Carcinoma
27. Serum WT1‑271 IgM antibody as a novel diagnostic marker for Gastric Cancer
28. Study on Scale Effects of Hydrodynamics around Prismatic Planing Surface by using CFD
29. Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers
30. Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers
31. 166 CLINICAL IMPACT OF NEW BIOMARKERS IN THE PATIENTS WITH ESOPHAGEAL CARCINOMA
32. Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
33. Preoperative low serum creatine kinase is associated with poor overall survival in the male patients with esophageal squamous cell carcinoma
34. Prevalence of serum galectin‑1 autoantibodies in seven types of cancer: A potential biomarker
35. Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer
36. Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma
37. Prevalence of autoantibodies against Ras‑like GTPases, RalA, in patients with gastric cancer
38. High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
39. Introducing the Coaxial Method of Catheter Port Implantation for Hepatic Arterial Infusion Chemotherapy
40. Erratum to: NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
41. Diagnostic impact of high serum midkine level in patients with gastric cancer
42. High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer.
43. PS02.052: AUTO-ANTIBODIES AGAINST TUMOR ANIGENS ARE USEFUL BIOMARKERS IN PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA
44. PS01.169: RADICAL ESOPHAGECTOMY COMBINED WITH RESECTION OF INVADED DESCENDING AORTA FOR T4 BARRETT’S ESOPHAGEAL CANCER
45. Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?
46. Relationship between ABO blood group and clinicopathological factors and their effect on the survival of Japanese patients with esophageal squamous cell carcinoma
47. Clinical significance of serum autoantibodies against Ras-like GTPases, RalA, in patients with esophageal squamous cell carcinoma
48. Erratum to: NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
49. NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
50. A Case of Diaphragmatic Hernia After Transhiatal Esophagectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.